CHIMERIC ANTIGEN RECEPTORS RECOGNIZING CANCER-SPECIFIC TN GLYCOPEPTIDE VARIANTS
    1.
    发明公开
    CHIMERIC ANTIGEN RECEPTORS RECOGNIZING CANCER-SPECIFIC TN GLYCOPEPTIDE VARIANTS 审中-公开
    KREBSSPEZIFISCHE TN-GLYCOPEPTIDVARIANTEN ERKENNENDECHIMÄREANTIGENREZEPTOREN

    公开(公告)号:EP3102236A4

    公开(公告)日:2017-08-30

    申请号:EP15746143

    申请日:2015-02-05

    申请人: UNIV CHICAGO

    摘要: Disclosed are binding proteins, or fragments thereof, that specifically binds to a cancer-specific glycosylation variant of a protein and to a second epitope on the same protein, to a different protein presented on the same cell, or to a different protein presented on a different cell, such as an encoded polypeptide binding to both a cancer cell and an activated T cell. Also disclosed are polynucleotides encoding such binding proteins, including polynucleotides comprising codon-optimized coding regions and polynucleotides comprising coding regions that are not codon-optimized for expression in a particular host cell. Also disclosed are methods of making the encoded polypeptide and methods of using the polypeptide to treat, prevent or ameliorate the symptom of a disease such as cancer.

    摘要翻译: 公开了结合蛋白或其片段,其特异性结合蛋白质的癌症特异性糖基化变体和相同蛋白质上的第二表位,存在于同一细胞上的不同蛋白质,或存在于存在于 不同的细胞,如编码的多肽与癌细胞和活化的T细胞都结合。 还公开了编码此类结合蛋白的多核苷酸,包括包含密码子优化的编码区的多核苷酸和包含未针对特定宿主细胞中的表达进行密码子优化的编码区的多核苷酸。 还公开了制备编码的多肽的方法和使用该多肽治疗,预防或缓解疾病例如癌症的症状的方法。

    ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS
    8.
    发明公开
    ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS 审中-公开
    ROLLE VON ADAM10 UND SEINE RELEVANZFÜRKRANKHEITEN UND THERAPEUTIKA

    公开(公告)号:EP2637679A4

    公开(公告)日:2015-09-23

    申请号:EP11839643

    申请日:2011-11-09

    申请人: UNIV CHICAGO

    IPC分类号: A61K38/04

    摘要: Certain embodiments are directed to compositions and methods of inhibiting pathogenic bacterial infection involving ADAMIO comprising administering an effective amount of a metalloprotease inhibitor to a patient. Certain embodiments are directed to method of inhibiting Staphylococcal infection comprising administering an effective amount of a metalloprotease inhibitor to a patient. Other embodiments concern methods of inhibiting infection by a bacteria from the genus Clostridium, Streptococcus, Listeria, Bacillus, or Arcanobacterium.

    摘要翻译: 某些实施方案涉及抑制涉及ADAMIO的致病性细菌感染的组合物和方法,包括向患者施用有效量的金属蛋白酶抑制剂。 某些实施方案涉及抑制葡萄球菌感染的方法,包括向患者施用有效量的金属蛋白酶抑制剂。 其他实施方案涉及抑制来自梭菌属,链球菌属,利斯特氏菌属,芽孢杆菌属或阿尔科杆菌属的细菌感染的方法。

    METHOD AND SYSTEM FOR CONVERTING ELECTRICITY INTO ALTERNATIVE ENERGY RESOURCES
    10.
    发明公开
    METHOD AND SYSTEM FOR CONVERTING ELECTRICITY INTO ALTERNATIVE ENERGY RESOURCES 审中-公开
    VERFAHREN UND SYSTEM ZUR UMWANDLUNG VONELEKTRIZITÄTIN ALTERNATIVE STRMRESSOURCEN

    公开(公告)号:EP2449084A4

    公开(公告)日:2013-12-11

    申请号:EP10794826

    申请日:2010-07-02

    申请人: UNIV CHICAGO

    发明人: METS LAURENS

    摘要: A system to convert electric power into methane includes a biological reactor has at least a first chamber containing at least a cathode, a culture comprising methanogenic microorganisms, and water, and a second chamber containing at least an anode. The biological reactor has an operating state wherein the culture is maintained at a temperature above 50 °C. The system also includes a source of electricity coupled to the anode and the cathode, a supply of carbon dioxide coupled to the first chamber, and an outlet to receive methane from the first chamber.

    摘要翻译: 将电力转化为甲烷的系统包括生物反应器具有至少包含至少一个阴极的第一室,包含产甲烷微生物的水和含有至少阳极的第二室。 生物反应器具有其中培养物保持在高于50℃的温度的操作状态。 该系统还包括耦合到阳极和阴极的电源,耦合到第一室的二氧化碳的供应和从第一室接收甲烷的出口。